Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | PTAFR | P25105 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL732313 | 0.85 | SMN1; SMN2 (0.52) | SMN1; SMN2CYP1A2TDP1KDM4ENOTUM | |
| SCHEMBL27508694 | 0.83 | SMN1; SMN2 (0.54) | SMN1; SMN2CYP1A2TDP1KDM4ENOTUM | |
| SCHEMBL29257696 | 0.78 | SMN1; SMN2 (0.48) | SMN1; SMN2CYP1A2TDP1KDM4ENOTUM | |
| SCHEMBL2187341 | 0.75 | — | — | |
| SCHEMBL4236 | 0.75 | — | — | |
| SCHEMBL17420841 | 0.74 | TSHR (0.65) | SMN1; SMN2TDP1KDM4EALDH1A1KMT2A | |
| SCHEMBL13173709 | 0.73 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP1A2TDP1KDM4EKMT2A | |
| SCHEMBL137219 | 0.73 | CYP1A2 (0.50) | SMN1; SMN2CYP1A2TDP1KDM4ENOTUM | |
| SCHEMBL13921120 | 0.73 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP1A2TDP1KDM4EKMT2A | |
| SCHEMBL11070126 | 0.73 | CYP1A2 (0.50) | SMN1; SMN2CYP1A2TDP1KDM4ENOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951179-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9951179-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-9624191-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624191-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-20160081343-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2016-03-24 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | WEE1, WEE2, THEM6 | SMN1; SMN2 4611/4885CYP1A2 2370/4885TDP1 2918/4885 |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | ACMSD, CARM1, PBRM1 | SMN1; SMN2 4168/4885CYP1A2 4445/4885TDP1 3817/4885 |
| US-20160081343-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | WEE1, WEE2, THEM6 | SMN1; SMN2 4611/4885CYP1A2 2370/4885TDP1 2918/4885 |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | ACMSD, CARM1, PBRM1 | SMN1; SMN2 4168/4885CYP1A2 4445/4885TDP1 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.